Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring

Despite extensive scientific progress in the melanoma field, treatment of advanced stage melanoma with chemotherapeutics and biotherapeutics has rarely provided response rates higher than 20%. In the past decade, targeted inhibitors have been developed for metastatic melanoma, leading to the advent...

Descripción completa

Detalles Bibliográficos
Autores principales: Klinac, Dragana, Gray, Elin S., Millward, Michael, Ziman, Mel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601325/
https://www.ncbi.nlm.nih.gov/pubmed/23515890
http://dx.doi.org/10.3389/fonc.2013.00054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601325/
https://www.ncbi.nlm.nih.gov/pubmed/23515890
http://dx.doi.org/10.3389/fonc.2013.00054

Ejemplares similares